IL10 and inflammation: In IL-10−/− mice, the development of intestinal inflammation was preceded by an increase in intestinal permeability [10], and enhancement of intestinal TJ barrier with a TJ barrier enhancing agent (AT-1001) prevented the development of intestinal inflammation [11].